6505--Abiraterone Acetate Tablets

Cancelled Pre-Solicitation Posted

Not the latest version. See the latest solicitation from .

Solicitation number
36E79724R0023
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs (VA) National Acquisition Center intends to issue a Request for Proposal (RFP) for an unrestricted procurement of Abiraterone Acetate Tablets. The contract will be for the VA (including Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The VA will award one contract with a one-year base period and four one-year option periods. Key requirements include unique NDC numbers, safety caps, and specific bottle and label specifications. The estimated annual usage is 71,997 bottles of 120-count 250mg tablets and 1,102 bottles of 60-count 500mg tablets. The solicitation will be issued electronically on or about September 18, 2024, with a tentative closing date of October 2, 2024. The NAICS code for this procurement is 325412.

This procurement is unrestricted, and there are no set-aside designations. The contract will be distributed through the VA's and DoD's Pharmaceutical Prime Vendor Programs. The value of the contract or budget range is not specified in the pre-solicitation notice. The point of contact for this procurement is Richard Mahario, and interested offerors should continuously check SAM.gov for any changes to the solicitation.

Notice text

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0023 for an unrestricted procurement for Abiraterone Acetate Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).

VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.

Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 and 2, (120 and 60 count bottles respectively)) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.

Solicitation # 36E79724R0023 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 18, 2024, with a tentative closing date of October 2, 2024. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to Richard.Mahario@va.gov.

The estimated annual requirements are as follows:

REQUIREMENT DESCRIPTION

ITEM

DESCRIPTION

PACKAGE SIZE (Tablets per Bottle)

TOTAL ESTIMATED ANNUAL USAGE (Bottles)

1

Abiraterone Acetate 250mg Tablets

120

71,997

2

Abiraterone Acetate 500mg Tablets

60

1,102

Files

File Type Posted
36E79724R0023_1.docx DOCX document

Notice history

Notice Type Posted
6505--Abiraterone Acetate Tablets Latest solicitation Solicitation
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside
6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 See Section 11 of the Cleveland and Kent, Ohio, United States · NAICS 325412 Veterans Integrated Service Network 10 No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity